Trials / Completed
CompletedNCT00938951
Evaluate the Ability of Systane Ultra to Improve Subjective Symptoms of Ocular Irritation Post 60 Min. Athletic Performance.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The primary objective of this study is to compare visual degradation in a stressed (forced stare) environment in patients before and after acute administration of Systane Ultra.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Systane® Ultra | Polyethylene Glycol 400 0.4% / Propylene Glycol 0.3% |
Timeline
- Start date
- 2009-06-01
- Primary completion
- 2009-07-01
- First posted
- 2009-07-14
- Last updated
- 2012-02-09
Source: ClinicalTrials.gov record NCT00938951. Inclusion in this directory is not an endorsement.